National
Obama earns mixed reviews on LGBT progress
Is the president our ‘fierce advocate’ or a disappointment?

Once hailed as a ‘fierce advocate’ of LGBT equality, President Obama now inspires mixed reviews from activists. (Photo by Pete Souza; courtesy of the White House)
After 18 months in office, the harsh realities of politics and compromise have caught up to President Obama. Hailed as a champion of LGBT rights during the 2008 campaign, LGBT rights advocates now give Obama mixed reviews for his performance to date.
In a statement to the Blade, Joe Solmonese, president of the Human Rights Campaign, said “there’s no doubt” that Obama has done more for LGBT people than any other U.S. president in history.
“Within the constraints of current law, he’s advanced policies that will vastly improve the lives of tens of millions,” Solmonese said. “Has change occurred quickly enough? No. The pace of change will never be quick enough for a community that is consistently denied their equality.”
Solmonese noted that LGBT people continue to face inequality on “a whole host of fronts” that could be remedied through legislative or policy change.
“But none of that obscures the fact that this president has and will continue to be our partner and advocate,” Solmonese said.
But Richard Socarides, a gay New York attorney who was an adviser to former President Clinton, has a very different view of Obama’s tenure. Socarides said there’s a “pretty strong consensus that it’s been a disappointing 18 months.”
Among Obama’s early disappointments, Socarides said, was the invitation to Rick Warren, pastor of the Saddleback Church in California and staunch opponent of same-sex marriage, to give the invocation during last year’s inauguration.
More recently, Socarides said he was unhappy that Obama approved a “Don’t Ask, Don’t Tell” repeal compromise that “did not include a non-discrimination rule, nor even actual repeal.”
“When Obama took office, these were our priorities: open military service, a federal statute banning workplace discrimination, and repeal of federal anti-marriage laws,” Socarides said. “You tell me how we’re doing.”
Socarides also criticized the White House for failing to install a senior official whose primary responsibility is LGBT rights, much like the role he held in the Clinton administration.
“There is no gay person in Obama’s inner circle, period,” Socarides said.
Shin Inouye, a White House spokesperson, said Obama ran on a commitment to bring change to all Americans — including LGBT people — and since taking office, the president has “taken many steps toward achieving that goal.”
Inouye noted the signing of federal hate crimes legislation as among Obama’s accomplishments for LGBT people and said the president looks forward to signing more pro-LGBT legislation.
“The president and his administration remain committed to achieving equality for all, and it’s clear that we’re moving forward,” Inouye said.
Two years ago, he issued an open letter during Pride month outlining his promises to the LGBT community.
“I’m running for president to build an America that lives up to our founding promise of equality for all — a promise that extends to our gay brothers and sisters,” Obama wrote at the time. “It’s wrong to have millions of Americans living as second‐class citizens in this nation. And I ask for your support in this election so that together we can bring about real change for all LGBT Americans.”
In the letter, Obama pledged to “place the weight” of his administration behind the enactment of hate crimes protections legislation and to pass a trans-inclusive Employment Non-Discrimination Act.
Obama has sometimes been credited with having a role in the decision to advance the hate crimes legislation last year as an amendment to defense authorization legislation.
Progress on ENDA, on the other hand, has been stagnant. The bill remains pending before committees in the House and Senate and many supporters are concerned that lawmakers won’t take up the bill by year’s end.
Mara Keisling, executive director of the National Center for Transgender Equality, noted that Obama “exerted appropriate influence” in guiding the hate crimes legislation toward passage.
On ENDA, Keisling said the administration has been “as helpful as they can be” to this point, and she expects the president “will be a lot more helpful once it starts moving.”
At this point, Keisling said “there really hasn’t yet been much for them to do” on ENDA.
Keisling noted that for congressional hearings on ENDA last year in the House and Senate, the administration sent officials who provided “really great testimony” in favor of moving forward with the legislation.
“If the president had prioritized ENDA instead of, I don’t know, health care reform or financial reform or bank bailouts, we’d be better off, but he prioritized what he prioritized,” she said. “I’m very hopeful that when ENDA does start moving, the White House will be extremely supportive and will help get it done.”
Also in the letter, Obama promised to “use the bully pulpit” to urge states to treat same-sex couples equally in their family and adoption laws. He additionally advocated for the establishment of civil unions as the best way to advance rights for LGBT couples.
“But I also believe that the federal government should not stand in the way of states that want to decide on their own how best to pursue equality for gay and lesbian couples — whether that means a domestic partnership, a civil union, or a civil marriage,” Obama wrote.
Additionally, the presidential candidate said he supported “complete repeal” of the Defense of Marriage Act.
“Federal law should not discriminate in any way against gay and lesbian couples, which is precisely what DOMA does,” Obama wrote.
Obama has stuck to his position on same-sex marriage as several jurisdictions — such as Iowa, Vermont, New Hampshire and D.C. — have advanced marriage rights for same-sex couples. The White House has either said nothing in response to those developments or reiterated that Obama prefers civil unions.
Evan Wolfson, executive director of the New York-based Freedom to Marry, said Obama has “taken some positive steps” in advocating for same-sex couples, but hasn’t “matched his actions to his words.”
Wolfson said Obama should be leading the fight to repeal DOMA legislatively through the Respect for Marriage Act, a bill pending in the U.S. House, and should stop urging judges to “rubberstamp” DOMA in Justice Department briefs defending the statute against legal challenges.
“And, most importantly, he should make the case to the American people that same-sex couples deserve fair and equal treatment under the law — using personal stories and appeals to values such as fairness, respect for commitment and the Golden Rule,” Wolfson said.
Another item that Obama mentioned in the letter is repeal of “Don’t Ask, Don’t Tell.” Late last month, Congress voted in favor of a compromise measure that would end the law after the Pentagon completes its study on the issue at the end of the year.
Alex Nicholson, executive director of Servicemembers United, said the White House’s endorsement of the compromise the week that Congress voted on it was helpful in finding the votes needed to advance the measure.
“The fact that the White House was willing to come out and publicly support a repeal plan and get the Pentagon to do the same was a critical element in getting that passed in the Senate Armed Services Committee,” Nicholson said.
Still, Nicholson said he didn’t know how involved Obama was in lobbying members of the House and Senate directly to vote in favor of repeal once the deal was reached.
Also in the letter, Obama pledged to work to address HIV/AIDS, arguing that “we do not have to choose between values and science” in working to fight the epidemic.
“While abstinence education should be part of any strategy, we also need to use common sense,” he wrote. “We should have age‐appropriate sex education that includes information about contraception.”
Carl Schmid, deputy executive director of the AIDS Institute, said he had mixed feelings about Obama’s track record on the matter.
“There have been a lot of positives, but there still needs to be greater attention in response and resources,” he said.
Schmid said Obama has followed through on his plans to confront HIV/AIDS through scientific means and has set out to eliminate “abstinence-only” sex education programs through the budget process.
But Schmid noted the abstinence-only sex education programs were reinstated by amendment in the passage of the health care reform legislation.
“It’s not in the appropriations bill, but it’s in the managerial program now, just like it was in the past,” he said.
Schmid cited the reauthorization of the Ryan White Care Act as an accomplishment regarding HIV/AIDS, as well as passage of health care reform legislation, which he called a “huge, huge, huge accomplishment.”
He said the White House was of limited help, though, in pushing to renew funding under the Ryan White Care Act.
“The administration was very slow in getting their principle and positions out on getting the Ryan White reauthorized,” he said. “They didn’t speak out and early enough. Ryan White is up for renewal in 2013 — right before all this health care reform kicks in. We’re going to need the administration’s support for the continuation of Ryan White after 2013.”
Noting a national AIDS strategy is currently being developed in the White House, Schmid said he hopes the plan will provide the discussion of homosexuality at appropriate ages in sex education programs because HIV is often transmitted through men who have sex with men.
Schmid gave Obama credit for lifting the travel ban that prevented foreign nationals with HIV from entering the country, although he noted this process began under the Bush administration with the passage of the President’s Emergency Plan for AIDS Relief legislation.
Obama closed his letter by calling on people to step “outside our comfort zone” to win broader support for LGBT rights in places often considered homophobic, such as black churches.
“If we want to repeal DOMA, repeal ‘Don’t Ask, Don’t Tell,’ and implement fully inclusive laws outlawing hate crimes and discrimination in the workplace, we need to bring the message of LGBT equality to skeptical audiences as well as friendly ones — and that’s what I’ve done throughout my career,” Obama wrote.
In the letter, Obama noted that he spoke out against homophobia during the presidential campaign at the Ebenezer Baptist Church in Atlanta, Ga., where Martin Luther King, Jr. once preached.
Obama also spoke out against homophobia during a February speech at the National Prayer Breakfast in D.C., a gathering of Christian evangelical leaders. And late last month, Obama spoke in favor of LGBT rights during his keynote speech at the National Association for the Advancement of Colored People’s centennial convention.
Sharon Lettman, executive director of the National Black Justice Coalition, said Obama has “absolutely” been faithful to his promise of speaking out in favor of LGBT rights in places that are sometimes deemed unfriendly to LGBT people.
“I’ve experienced it on a number of occasions in predominantly black or all black venues,” she said. “Even in his normal stump speech, he makes reference to his support of LGBT equality.”
Lettman said as the first black president, Obama has a special role to play in educating black Americans about the LGBT community.
“He makes a point to always be inclusive,” she said. “He doesn’t selectively leave it out — not just in black churches, but in front of civil rights leaders and civil rights venues, like the NAACP convention, and other areas.”
Lettman said Obama is “definitely trying to paint a picture of one America” in his actions and his speeches.
“In so many ways, even in the progressive agenda, people don’t always select to include our community,” she said, “and I have to give him a lot of credit for making sure that he speaks with one voice about his support for LGBT equality.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
